ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $26.5. This is a potential upside of $5.19 (24.35%) from yesterday's end of day stock price of $21.31.

ADMA Biologics's activity chart (see below) currently has 28 price targets and 54 ratings on display. The stock rating distribution of ADMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.79% with an average time for these price targets to be met of 822.14 days.

Highest price target for ADMA is $26, Lowest price target is $14, average price target is $22.5.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 04-Mar-2025. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 24 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$25

$5.6 (28.87%)

$20

1 months 13 days ago
(04-Mar-2025)

8/9 (88.89%)

$7.99 (46.97%)

138

Buy

$25

$5.6 (28.87%)

$10

5 months 9 days ago
(08-Nov-2024)

5/6 (83.33%)

$2.38 (10.52%)

632

Buy

$26

$6.6 (34.02%)

$18

5 months 9 days ago
(08-Nov-2024)

14/15 (93.33%)

$3.38 (14.94%)

298

$14

$-5.4 (-27.84%)

$12

9 months 28 days ago
(20-Jun-2024)

7/7 (100%)

$3.29 (30.72%)

529

Buy

$4

$-15.4 (-79.38%)

$7

4 years 5 months 11 days ago
(06-Nov-2020)

6/6 (100%)

$2.09 (109.42%)

1736

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 822.14 days on average for the stock forecasts to be realized with a an average price target met ratio 80.79

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Jason Kolbert has 5 price targets and 10 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Raghuram Selvaraju with highest potential upside - $6.6

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with lowest potential downside - -$15.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?